|
SLC7A6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.67164110015983E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.49324996812084E-13 |
| Normal-vs-Stage2 |
1.19179999202856E-10 |
| Normal-vs-Stage3 |
2.67563748934663E-14 |
| Normal-vs-Stage4 |
1.62481139653892E-12 |
| Stage1-vs-Stage2 |
2.688000E-01 |
| Stage1-vs-Stage3 |
3.140600E-01 |
| Stage1-vs-Stage4 |
1.857510E-03 |
| Stage2-vs-Stage3 |
1.321440E-01 |
| Stage2-vs-Stage4 |
6.559700E-03 |
| Stage3-vs-Stage4 |
1.060010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69375624636814E-12 |
| Normal-vs-AfricanAmerican |
2.15110000001406E-06 |
| Normal-vs-Asian |
1.67155178587564E-12 |
| Caucasian-vs-AfricanAmerican |
6.157000E-01 |
| Caucasian-vs-Asian |
6.301000E-01 |
| AfricanAmerican-vs-Asian |
5.197200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8034462812011E-12 |
| Normal-vs-Female |
6.3948846218409E-14 |
| Male-vs-Female |
6.696000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.73745520379998E-14 |
| Normal-vs-Age(41-60Yrs) |
3.28626015289046E-14 |
| Normal-vs-Age(61-80Yrs) |
5.08582065350538E-12 |
| Normal-vs-Age(81-100Yrs) |
1.643860E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.947600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.524000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.237600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.720800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.032600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.708200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.14170000000436E-05 |
| Classical-VS-Follicular |
2.464800E-03 |
| Classical-VS-Other |
8.766800E-01 |
| Classical-VS-Normal |
1.78101977610368E-12 |
| Tall-VS-Follicular |
9.29889998335653E-09 |
| Tall-VS-Other |
2.912400E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
3.925400E-01 |
| Follicular-VS-Normal |
2.56169974122145E-10 |
| Other-VS-Normal |
8.791700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.19624318731348E-12 |
| Normal-vs-N1 |
1.68132174849234E-12 |
| N0-vs-N1 |
9.406200E-02 |
|
|
